|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ALTH 8-K filed Aug 4, 2009. Item 2.02 Results of Operations and Financial Condition.
On August 4, 2009, Allos Therapeutics, Inc., a Delaware corporation, issued a press release reporting financial results for the second quarter of 2009. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Section 9 Financial Statements and Exhibits
This excerpt taken from the ALTH 8-K filed May 5, 2009. Item 2.02 Results of Operations and Financial Condition.
On May 5, 2009, Allos Therapeutics, Inc., a Delaware corporation, issued a press release reporting financial results for the first quarter of fiscal year 2009. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Section 9 Financial Statements and Exhibits
This excerpt taken from the ALTH 8-K filed Mar 3, 2009. Item 2.02 Results of Operations and Financial Condition.
On March 3, 2009, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release reporting results for its fiscal year ended December 31, 2008 and outlining its key objectives for 2009.
The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Section 9 Financial Statements and Exhibits
This excerpt taken from the ALTH 8-K filed May 7, 2008. Results of Operations
and Financial Condition.
On May 7, 2008, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the first quarter of fiscal year 2008. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
This excerpt taken from the ALTH 8-K filed Feb 27, 2008. Item 2.02 Results of Operations and Financial Condition.
On February 27, 2008, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for fiscal year 2007. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Section 9 - Financial Statements and Exhibits
This excerpt taken from the ALTH 8-K filed Nov 5, 2007. Item 2.02. Results of Operations and Financial Condition.
On November 5, 2007, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the third quarter of fiscal year 2007. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exhibits This excerpt taken from the ALTH 8-K filed Aug 7, 2007. Item 2.02. Results of Operations and Financial Condition. On August 7, 2007, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the second quarter of fiscal year 2007. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exhibits This excerpt taken from the ALTH 8-K filed May 8, 2007. Item 2.02 Results of Operations and Financial Condition. On May 8, 2007, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the first quarter of fiscal year 2007. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exhibits This excerpt taken from the ALTH 8-K filed Mar 5, 2007. Item 2.02 Results of Operations and Financial Condition. On March 5, 2007, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for fiscal year 2006. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exhibits This excerpt taken from the ALTH 8-K filed Nov 3, 2006. Item 2.02 Results of Operations and Financial Condition On November 3, 2006, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the third quarter of fiscal year 2006. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. This excerpt taken from the ALTH 8-K filed Aug 7, 2006. Item 2.02 Results of Operations and Financial Condition On August 7, 2006, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the second quarter of fiscal year 2006. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing. This excerpt taken from the ALTH 8-K filed May 9, 2006. Item 2.02 Results of Operations and Financial Condition
On May 9, 2006, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the first quarter of fiscal year 2006. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
This excerpt taken from the ALTH 8-K filed Mar 6, 2006. Item 2.02 Results of Operations and Financial Condition
On March 6, 2006, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for fiscal year 2005. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
This excerpt taken from the ALTH 8-K filed Nov 9, 2005. Item 2.02 Results of Operations and Financial Condition
On November 9, 2005, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the third quarter of fiscal year 2005. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
This excerpt taken from the ALTH 8-K filed May 5, 2005. Item 2.02 Results of Operations and Financial Condition
On May 5, 2005, Allos Therapeutics, Inc., a Delaware corporation (the “Company”), issued a press release relating to the Company’s financial results for the first quarter of fiscal year 2005. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
| EXCERPTS ON THIS PAGE: |
| |||||||
